MSH2 and prostate cancer: Mean PSA concentration at prostate cancer diagnosis was 19·7 ng/mL (SD 8·9) in MSH2 carriers compared with 5·3 ng/mL (SD 0) in MSH2 non-carrier controls (p=0·56).